Yutaka Shirai

656 total citations
14 papers, 543 citations indexed

About

Yutaka Shirai is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Yutaka Shirai has authored 14 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Psychiatry and Mental health. Recurrent topics in Yutaka Shirai's work include Neuroscience and Neuropharmacology Research (5 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Schizophrenia research and treatment (3 papers). Yutaka Shirai is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Schizophrenia research and treatment (3 papers). Yutaka Shirai collaborates with scholars based in Japan, Finland and Poland. Yutaka Shirai's co-authors include Naoaki Saito, Yasuo Kajimoto, Chikako Tanaka, Takeshi Hashimoto, Naoki Nishino, Takayoshi Kuno, Osamu Shirakawa, Hideyuki Mukai, Tatsuo Mita and Noboru Kitamura and has published in prestigious journals such as Biological Psychiatry, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Yutaka Shirai

14 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutaka Shirai Japan 10 326 291 97 59 58 14 543
Wawa Zhu United States 8 396 1.2× 261 0.9× 121 1.2× 45 0.8× 56 1.0× 8 680
Brian R. Pearce United Kingdom 10 365 1.1× 425 1.5× 90 0.9× 120 2.0× 58 1.0× 13 629
Steven K. Harmon United States 9 436 1.3× 427 1.5× 48 0.5× 38 0.6× 43 0.7× 11 625
Georgiann Collinsworth United States 9 440 1.3× 284 1.0× 39 0.4× 40 0.7× 105 1.8× 9 718
Marion Lautenschlager Germany 11 180 0.6× 204 0.7× 158 1.6× 43 0.7× 38 0.7× 17 608
Manuela Mazzuferi Italy 14 421 1.3× 411 1.4× 212 2.2× 30 0.5× 54 0.9× 17 757
Laurie P. Sutton United States 15 394 1.2× 282 1.0× 53 0.5× 34 0.6× 40 0.7× 19 600
Celestine T. O’Shaughnessy United Kingdom 13 281 0.9× 320 1.1× 55 0.6× 84 1.4× 87 1.5× 24 552
Ryohei Iwata Japan 11 438 1.3× 221 0.8× 78 0.8× 50 0.8× 37 0.6× 19 648
K.‐H. Braunewell Germany 16 335 1.0× 295 1.0× 58 0.6× 100 1.7× 153 2.6× 20 620

Countries citing papers authored by Yutaka Shirai

Since Specialization
Citations

This map shows the geographic impact of Yutaka Shirai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Shirai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Shirai more than expected).

Fields of papers citing papers by Yutaka Shirai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Shirai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Shirai. The network helps show where Yutaka Shirai may publish in the future.

Co-authorship network of co-authors of Yutaka Shirai

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Shirai. A scholar is included among the top collaborators of Yutaka Shirai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Shirai. Yutaka Shirai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Puttonen, Henri, et al.. (2017). Knockout of histamine receptor H3 alters adaptation to sudden darkness and monoamine levels in the zebrafish. Acta Physiologica. 222(3). 9 indexed citations
2.
Okazaki, Kenji, Shuken Boku, Ikuo Otsuka, et al.. (2016). The cell cycle-related genes as biomarkers for schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 70. 85–91. 23 indexed citations
3.
Hatta, Kotaro, Kiyoshi Fujita, Shin Ito, et al.. (2014). Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia. Schizophrenia Research. 158(1-3). 213–222. 19 indexed citations
4.
Hatta, Kotaro, Yasuhiko Sudo, Yutaka Shirai, et al.. (2013). The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophrenia. Psychiatry Research. 210(2). 396–401. 7 indexed citations
5.
Shirai, Yutaka. (2005). Pine forests on western part of the Shimosa Upland. 9(2). 12–18. 4 indexed citations
6.
Saito, Naoaki & Yutaka Shirai. (2002). Protein Kinase C  (PKC ): Function of Neuron Specific Isotype. The Journal of Biochemistry. 132(5). 683–687. 172 indexed citations
7.
Kitamura, Noboru, Naoki Nishino, Takeshi Hashimoto, et al.. (1998). Asymmetrical changes in the fodrin α subunit in the superior temporal cortices in schizophrenia. Biological Psychiatry. 43(4). 254–262. 9 indexed citations
8.
Shirai, Yutaka, Osamu Shirakawa, Naoki Nishino, Naoaki Saito, & Hisao Nakai. (1996). Increased striatal glutamate transporter by repeated intermittent administration of methamphetamine. Psychiatry and Clinical Neurosciences. 50(3). 161–164. 18 indexed citations
9.
Nishino, Naoki, et al.. (1996). Increased Glutamate Transporter (GLT‐1) Immunoreactivity in the Rat Striatum after Repeated Intermittent Administration of Methamphetaminea. Annals of the New York Academy of Sciences. 801(1). 310–314. 3 indexed citations
10.
Hashimoto, Takeshi, Noboru Kitamura, Yasuo Kajimoto, et al.. (1993). Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia. Psychopharmacology. 112(S1). S35–S39. 88 indexed citations
11.
Kajimoto, Yasuo, Yutaka Shirai, Hideyuki Mukai, Takayoshi Kuno, & Chikako Tanaka. (1993). Molecular Cloning of Two Additional Members of the Neural Visinin‐Like Ca2+‐Binding Protein Gene Family. Journal of Neurochemistry. 61(3). 1091–1096. 52 indexed citations
12.
Nishino, Naoki, Noboru Kitamura, Takeshi Hashimoto, et al.. (1993). Increase in [3H]cAMP binding sites and decrease in Giα and Goα immunoreactivities in left temporal cortices from patients with schizophrenia. Brain Research. 615(1). 41–49. 37 indexed citations
13.
Kajimoto, Yasuo, Takeshi Hashimoto, Yutaka Shirai, et al.. (1992). cDNA Cloning and Tissue Distribution of a Rat Ubiquitin Carboxyl-Terminal Hydrolase PGP9.51. The Journal of Biochemistry. 112(1). 28–32. 40 indexed citations
14.
Kuno, Takayoshi, Yasuo Kajimoto, Takeshi Hashimoto, et al.. (1992). cDNA cloning of a neural visinin-like Ca2+-binding protein. Biochemical and Biophysical Research Communications. 184(3). 1219–1225. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026